Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: RXGOLF who wrote (15424)	2/20/1998 12:06:00 AM
From: Machaon	Read Replies (1) \| Respond to of 32384

<< By the way, some here have even done well with Ligand even though you note the price is about the same. >> I've been in and out of lGND. At present I am long only and not trading. It might take a while, but I want to be holding when and if LGND pops. Since there has been some discussion about the news releases, let's take a look and see what one of them means. Comments are welcome! << SAN DIEGO, Feb. 19 /PRNewswire/ -- Ligand Pharmaceuticals Inc. (Nasdaq: LGND) has announced the appointment of Philip A. Duffy to the newly created position of Vice President, Technical Operations. Mr. Duffy will oversee Ligand's chemical, formulations and analytical development activities for commercial products, as well as manufacturing, purchasing, and materials management functions. >> It's a newly created position. The positive side is that Ligand might be getting ready for another corporate function. The negative spin would be that Ligand needed a slot to reward one of their members of management. Any comments? Next: "Mr. Duffy will oversee Ligand's chemical, formulations and analytical development activities for commercial products" What commercial products? Perhaps this is a misstatement. Might we get a corrected release tomorrow saying "products under development" rather than "commercial products"? I guess that it is possible. If Ligand doesn't correct the news release, then what do they mean by commercial products? Could they be interested in selling peanut butter after reading this thread? << as well as manufacturing, purchasing, and materials management functions >> Could they be referring to the drugs under development? Why would they need someone in charge of manufacturing, etc., at this stage in testing? I guess it is possible. Could they be referring to the "ramping up" towards commercialization of products after FDA approval? Hmmmm!? They did say commercial products". To me this is a significant news release. It should have a positive effect on LGND tomorrow. Perhaps we'll see a move up of around 3/8? Anyone got an opinion?

To: RXGOLF who wrote (15424)	2/20/1998 8:16:00 AM
From: tonyt	Respond to of 32384

The 'posts about my DELL post' now outnumber my DELL posts! > But I doubt if anybody here cares that my parents made money in Wal Mart or > what my cousins dog does with Purina. You must be a new 'threadster', otherwise you would remember the Football posts, the high-school soccor posts, and the Monica posts (not to mention all of the other off-topic posts). :-) --Tony

To: RXGOLF who wrote (15424)	2/22/1998 9:42:00 AM
From: tonyt	Respond to of 32384

> But I doubt if anybody here cares that my parents made money in Wal > Mart or what my cousins dog does with Purina. What's your thoughts on the upcoming soccer season? :-)

To: RXGOLF who wrote (15424)	2/22/1998 10:49:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

RXGOLF, Actually, I think that you would be surprised at the visitor list to the Striker Web Site. It was heavily loaded with views from Pharmas and Biotechs. I'm not sure if this was because I posted the site location here a few times, or if it stems from the fact that the Web Site is the parent directory for Links to Ligand: home.att.net Sometimes viewers just delete the sub-directories, so when they enter: home.att.net they get the Striker Web Site. The Striker site as well as Links to Ligand have been very popular and I'm sure that the Striker site has a higher frequency of Pharmaceutical and Biotech visitors than most soccer sites. The over-all visitors list isn't that different than Links to Ligand, although the Strikers seem to attract more government visitors: Where Your Visitors Came From Visitors From Number USA Commercial 498 Network 486 USA Educational 61 Non-Profit Organizations 7 USA Government 99 Canada 5 USA Military 23 France 1 Germany 6 Austria 1 United Arab Emirates 1 Ireland 1 Israel 2 Netherlands 2 New Zealand 1 United Kingdom 2 United States 20